These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29404757)

  • 1. Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP.
    Hartmann M; McConnell M; Bekker LG; Celum C; Bennie T; Zuma J; van der Straten A
    AIDS Behav; 2018 Nov; 22(11):3468-3479. PubMed ID: 29404757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
    Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
    AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male partners' influence on women's acceptance and use of PrEP products across two high HIV-burdened districts in South Africa.
    Mbewe L; Govender E
    Afr J AIDS Res; 2020 Jul; 19(2):93-100. PubMed ID: 32320329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "You Never Know What Could Happen": Women's Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence.
    Willie TC; Keene DE; Kershaw TS; Stockman JK
    Womens Health Issues; 2020; 30(1):41-48. PubMed ID: 31537431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa.
    Vazquez L; Moll AP; Kacin A; Ndlovu NE; Shenoi SV
    AIDS Patient Care STDS; 2019 May; 33(5):214-219. PubMed ID: 31067125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
    Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
    BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
    Maseko B; Hill LM; Phanga T; Bhushan N; Vansia D; Kamtsendero L; Pettifor AE; Bekker LG; Hosseinipour MC; Rosenberg NE
    PLoS One; 2020; 15(1):e0226062. PubMed ID: 31929547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.
    Hartmann M; Montgomery E; Stadler J; Laborde N; Magazi B; Mathebula F; van der Straten A
    Cult Health Sex; 2016; 18(6):611-24. PubMed ID: 26551920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
    Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
    BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement.
    Mitchell JW; Lee JY; Woodyatt C; Bauermeister J; Sullivan P; Stephenson R
    AIDS Care; 2016 Aug; 28(8):994-9. PubMed ID: 27055001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and the association with relationship quality in South African couples: Implications for HIV/AIDS interventions.
    Conroy AA; McGrath N; van Rooyen H; Hosegood V; Johnson MO; Fritz K; Marr A; Ngubane T; Darbes LA
    Soc Sci Med; 2016 Mar; 153():1-11. PubMed ID: 26859436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the relationship context for couple-based HIV prevention: Elucidating women's perspectives on non-traditional sexual partnerships.
    Crankshaw TL; Voce A; Butler LM; Darbes L
    Soc Sci Med; 2016 Oct; 166():169-176. PubMed ID: 27566046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa.
    Govender E; Abdool Karim Q
    AIDS Care; 2018 Oct; 30(10):1311-1314. PubMed ID: 29914270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to use short-term oral pre-exposure prophylaxis (PrEP) by migrant miners and female partners of migrant miners in Mozambique.
    Falcao J; Ahoua L; Zerbe A; di Mattei P; Baggaley R; Chivurre V; Mulondo P; Ramiro I; Dalal S; Morales F; O'Reilly K; El-Sadr W
    Cult Health Sex; 2017 Dec; 19(12):1389-1403. PubMed ID: 28468533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "You tell him that 'baby, I am protecting myself'": Women's agency and constraint around willingness to use pre-exposure prophylaxis in the Masibambane Study.
    Harrison A; Bhengu N; Miller L; Exner T; Tesfay N; Magutshwa S; Khumalo S; Bergam S; Hoffman S; Hanass-Hancock J
    Womens Health (Lond); 2022; 18():17455057221087117. PubMed ID: 35306944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.